반응식
[CH:1]([N:14]1[C:22]2[C:17](=[CH:18][C:19](Br)=[CH:20][CH:21]=2)[CH:16]=[C:15]1[C:24]([OH:26])=[O:25])([C:8]1[CH:13]=[CH:12][CH:11]=[CH:10][CH:9]=1)[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1.[S:27]1[CH:31]=[CH:30][CH:29]=[C:28]1B(O)O>>[CH:1]([N:14]1[C:22]2[C:17](=[CH:18][C:19]([C:28]3[S:27][CH:31]=[CH:30][CH:29]=3)=[CH:20][CH:21]=2)[CH:16]=[C:15]1[C:24]([OH:26])=[O:25])([C:8]1[CH:13]=[CH:12][CH:11]=[CH:10][CH:9]=1)[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1참가 물질
3
실험 절차
The title compound was prepared according to the procedure described in Example 109 except that 1-benzhydryl-5-bromo-1H-indole-2-carboxylic acid and 2-thiopheneboronic acid were used.
출처 및 근거
- ORD 기록
- ord-da33c6b9179c41dbb7aac667ccb7412e
- 출처 데이터셋
- uspto-grants-2003_10
- 특허 번호
- US06630496B1
연결된 노트
불러오는 중…